| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183112 Administering locally to the area of inflammation to an animal an anti-inflammatory effective amount of an anti-malaria compound which is aminoquinoline or derivative |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183065 Diagnosing ulcerative colitis in humans; obtain sample tissue, incubate with histone antigen, detect presence of complex formation, presence of complex indicates ulcerative colitis |
| 02/27/2007 | US7182971 Comprising 15-70% by weight of diglycerides in which less than 15% by weight of constitutive fatty acids are omega 3 type unsaturated fatty acids, and 30-85% by weight of a triglyceride in which at least 15% by weight of constitutive fatty acids are omega 3 type; for oral medicinal formulations and foods |
| 02/27/2007 | CA2240281C Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| 02/22/2007 | WO2007021574A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | WO2007021573A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020830A1 Oral composition |
| 02/22/2007 | WO2007020617A2 Sequences of megaplasmid pmp118, chromosomal sequences and individual sequences thereof of lactobacillus salivarius strain ucc118 |
| 02/22/2007 | WO2006097263A3 Orally used compatible solute containing agents |
| 02/22/2007 | WO2006081431A3 Compounds for treating inflammatory and demyelinating diseases |
| 02/22/2007 | WO2005112881A8 The dispersible montmorillonite tablet and its preparation technology |
| 02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 02/22/2007 | US20070043026 Dopamine receptor modulators as antipsychotic agents |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070043004 High drug load mesalazine sachet |
| 02/22/2007 | US20070042992 Inulin products with improved nutritional properties |
| 02/22/2007 | US20070042990 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 02/22/2007 | US20070042043 Pellet formulations of acid-labile benzimidazonle compounds |
| 02/22/2007 | US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 02/22/2007 | US20070041938 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 02/22/2007 | US20070041913 Tooth coating composition |
| 02/22/2007 | CA2619751A1 Rotavirus vaccine inducing heterotypic cross protection |
| 02/22/2007 | CA2618895A1 Methods and compositions for soothing oral and nasal tissues |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2616318A1 Acetylenic piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | CA2616308A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | CA2616307A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/21/2007 | EP1754480A2 Compositions comprising phospholipase c inhibitors and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
| 02/21/2007 | EP1753742A2 Magnesium complexes of s-omeprazole |
| 02/21/2007 | EP1753429A1 Modulators of muscarinic receptors |
| 02/21/2007 | EP1753426A2 Ruminant treatments |
| 02/21/2007 | EP1753409A2 Dosage form containing the active ingredient cholylsarcosine |
| 02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1414316B1 Nutritional composition preventing bacterial overgrowth |
| 02/21/2007 | EP1389466B1 A dispersion on the basis of beta-glucan containing superfine particles, a corresponding process of manufacturing and the use of said dispersion |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1255749B1 Tyrosine derivatives with anti-leukotriene activity |
| 02/21/2007 | EP1224155B1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 02/21/2007 | EP1140071B1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 02/21/2007 | EP1133474B1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/21/2007 | EP1104438B1 Novel anti-diabetic peptides |
| 02/21/2007 | EP1086117B1 Cloning and identification of the motilin receptor |
| 02/21/2007 | CN2870840Y Tooth paste |
| 02/21/2007 | CN1918298A Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 02/21/2007 | CN1918290A Screening method |
| 02/21/2007 | CN1918157A Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1917903A New combinations of an anti emetic agent and an enkephalinase inhibitor |
| 02/21/2007 | CN1917899A Use of alkaline phosphatase for the detoxification of lps |
| 02/21/2007 | CN1917860A Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
| 02/21/2007 | CN1916013A Pharmaceutical compounds |
| 02/21/2007 | CN1915981A 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 02/21/2007 | CN1915971A Prostaglandin-like compound and its uses for treatment of external secretion disorders |
| 02/21/2007 | CN1915423A Preparation of Chinese traditional medicine for treating gastric disease, and preparation method |
| 02/21/2007 | CN1915422A Medication of medical broth for treating disease of wean alvine flux in type of chronic diarrhea, and preparation method |
| 02/21/2007 | CN1915421A Medication of medical broth for treating disease of wean alvine flux in type of damp heat, and preparation method |
| 02/21/2007 | CN1915418A Medication of medical broth for treating disease of wean alvine flux, and preparation method |
| 02/21/2007 | CN1915417A Medication of medical broth for treating for treating disease of vertigo in type of interior retention of phlegm dampness, and preparation method |
| 02/21/2007 | CN1915416A Medication of medical broth for treating disease of vertigo in type of phlegm fire, and preparation method |
| 02/21/2007 | CN1915415A Medication of pasting on umbilicus for treating wean fastidium, and preparation method |
| 02/21/2007 | CN1915414A Medication of medical broth for treating disease of wean alvine flux in type of deficient spleen and stomach cold, and preparation method |
| 02/21/2007 | CN1915413A Medication of medical broth for treating disease of wean alvine flux in type of abdominal distension, and preparation method |
| 02/21/2007 | CN1915412A Medication of medical broth for treating disease of wean alvine flux in type of abdominal pain, and preparation method |
| 02/21/2007 | CN1915411A Prepared Chinese medicine for treating disease of alimentary canal and herbalist doctor described typhoid fever, and preparation method |
| 02/21/2007 | CN1915409A Medication of medical broth for treating wean fastidium in type of stagnation of qi of the liver and stomach, and preparation method |
| 02/21/2007 | CN1915408A Compound preparation of Chinese traditional medicine in use for treating fatty liver, and preparation method |
| 02/21/2007 | CN1915398A Medication of medical broth for treating wean fastidium in type of depressed liver and retention of food, and preparation method |
| 02/21/2007 | CN1915397A Medication of medical broth for treating wean fastidium in type of the depressed liver with the insufficient spleen, and preparation method |
| 02/21/2007 | CN1915391A Medication of medical broth for treating wean fastidium in type of food stasis in middle warmer, and preparation method |
| 02/21/2007 | CN1915383A Medication of medical broth for treating disease of wean hotness in type of damaged lung and stomach, and preparation method |
| 02/21/2007 | CN1915381A Medication of medical broth for treating disease of wean infantile malnutrition, and preparation method |
| 02/21/2007 | CN1915379A Medication of medical broth for treating disease of wean infantile malnutrition in type of latent damp, and preparation method |
| 02/21/2007 | CN1915372A Medical food for treating wean infantile malnutrition, and preparation method |
| 02/21/2007 | CN1915361A Medication of medical broth for treating astriction, and preparation method |
| 02/21/2007 | CN1915350A Composition of medication for treating gastric disease |
| 02/21/2007 | CN1915347A Medication of medical broth for treating wean infantile malnutrition in type of retention of food in the stomach, and preparation method |
| 02/21/2007 | CN1915346A External remedy of cholagogue, and application |
| 02/21/2007 | CN1915345A External preparation of Chinese traditional medicine for improving ascites due to cirrhosis, and preparation method |
| 02/21/2007 | CN1915340A Medication of medical broth for treating disease of vertigo in deficiency of liver-yin and kidney-yin type, and preparation method |
| 02/21/2007 | CN1915331A Medication of medical broth for treating disease of wean infantile malnutrition in deficiency of qi type and preparation method |
| 02/21/2007 | CN1915329A Medication for pasting on umbilicus to treat ache in cold syndrome of the stomach type, and preparation method |
| 02/21/2007 | CN1915324A Preparation of reenforcing spleen for wean, and preparation method |
| 02/21/2007 | CN1915323A Medication of medical broth for treating habitual constripation, and preparation method |
| 02/21/2007 | CN1915313A Medicinal food for treating night sweat disease in deficency of the splinic qi type, and preparation method |
| 02/21/2007 | CN1915312A Medication of steeping foot for treating ulcer in the oral cavity, and preparation method |